Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:986-991

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Podjarny, E.
Right arrow Articles by Bernheim, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Podjarny, E.
Right arrow Articles by Bernheim, J.

(Hypertension. 1997;29:986-991.)
© 1997 American Heart Association, Inc.


Articles

Pregnancy-Induced Hypertension in Rats With Adriamycin Nephropathy Is Associated With an Inadequate Production of Nitric Oxide

Eduardo Podjarny; Sidney Ben-Chetrit; Mauro Rathaus; Zeev Korzets; Janice Green; Bernard Katz; ; Jacques Bernheim

From the Department of Nephrology and Hypertension, Meir Hospital, Sackler School of Medicine, University of Tel-Aviv (Israel).

Correspondence to Prof J. Bernheim, Meir Hospital, 44281 Kfar Saba, Israel.

Abstract Hypertensive complications are relatively common in pregnancy, particularly in the presence of preexisting renal disease. Although the pathogenesis of such complications is still unknown, recent animal studies have suggested that it may be related to impaired synthesis of nitric oxide (NO). Rats with adriamycin nephropathy develop a "preeclamptic-type" pregnant state characterized by elevated blood pressure, lack of hyperfiltration, and enhanced proteinuria. Preliminary studies with this model have implicated inadequate NO synthesis in the development of preeclamptic-like pregnancy. The aim of the present study was to confirm this hypothesis. Pregnant rats, both normal (PREG) and those with adriamycin nephropathy (AN-PREG), received 100 mg/L N{omega}-nitro-L-arginine methyl ester PO from the middle of gestation to term (day 11, term approximately 22 days). One group of AN-PREG rats received either L-arginine or D-arginine (2 g/L) from midpregnancy. At term, systolic pressure, mean arterial pressure, urinary metabolites of NO, creatinine clearance, and urinary protein were assessed. At term, compared with virgin rats with adriamycin nephropathy, untreated AN-PREG rats had increased systolic pressure, mean arterial pressure, and proteinuria (mean arterial pressure, 124±2.5 versus 99.7±1.6 mm Hg [P<.05]; proteinuria, 434±58 versus 216±63 mg/d [P<.05]). Creatinine clearance did not change (1.68±0.23 versus 1.35±0.09 mL/min, P=NS). In PREG rats, urinary metabolites of NO increased approximately threefold at term pregnancy compared with control. By contrast, in AN-PREG rats, excretion of urinary metabolites of NO increased only by approximately 1.7-fold (P<.01) versus PREG rats. With the exception of AN-PREG rats, inhibition of NO synthesis with N{omega}-nitro-L-arginine methyl ester enhanced blood pressure and decreased creatinine clearance but did not influence proteinuria. Excretion of urinary metabolites of NO was similarly inhibited in all rats. In AN-PREG rats, L-arginine normalized blood pressure (91±2.15 mm Hg) and lowered proteinuria partially but significantly. D-Arginine had no effect. In summary, AN-PREG rats are unable to adequately increase NO synthesis when physiologically required. Correction of this deficit by L-arginine treatment induced a significant clinical improvement.


Key Words: doxorubicin • pregnancy • rats • nitric oxide




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. L. Kolo, T. C. Westfall, and H. Macarthur
Modulation of neurotransmitter release by NO is altered in mesenteric arterial bed of spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1842 - H1847.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. L. Kolo, T. C. Westfall, and H. Macarthur
Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed
Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H296 - H303.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. K. RANGAN, Y. WANG, and D. C. H. HARRIS
Pharmacologic Modulators of Nitric Oxide Exacerbate Tubulointerstitial Inflammation in Proteinuric Rats
J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1696 - 1705.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Nakai, H. Asakura, A. Oya, A. Yokota, T. Koshino, and T. Araki
Pulsed Doppler US Findings of Renal Interlobar Arteries in Pregnancy-induced Hypertension
Radiology, November 1, 1999; 213(2): 423 - 428.
[Abstract] [Full Text]